Ngā hua rapu - Loïc Guillevin
- E whakaatu ana i te 1 - 20 hua o te 134
- Haere ki te Whārangi Whai Ake
-
1
-
2
Vasculitis: mechanisms involved and clinical manifestations mā Loı̈c Guillevin, Thomas Dörner
I whakaputaina 2007Revisão -
3
Polyarteritis Nodosa Neurologic Manifestations mā Hubert de Boysson, Loı̈c Guillevin
I whakaputaina 2019Revisão -
4
-
5
-
6
-
7
-
8
Infection and vasculitis mā C. C. Belizna, M. Hamidou, H. Lévesque, Loïc Guillevin, Y. Shoenfeld
I whakaputaina 2008Revisão -
9
-
10
Scleroderma Renal Crisis mā Luc Mouthon, Guillaume Bussone, A. Bérezné, Laure‐Hélène Noël, Loı̈c Guillevin
I whakaputaina 2014Revisão -
11
-
12
Central Nervous System Involvement in Wegener Granulomatosis mā Raphaèle Séror, Alfred Mahr, J. Ramanoelina, Christian Pagnoux, Pascal Cohen, Loı̈c Guillevin
I whakaputaina 2006Artigo -
13
-
14
Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schönlein Purpura mā Évangéline Pillebout, Corinne Alberti, Loı̈c Guillevin, Amel Ouslimani, Éric Thervet, the CESAR study group
I whakaputaina 2010Artigo -
15
The Five-Factor Score Revisited mā Loı̈c Guillevin, Christian Pagnoux, Raphaèle Séror, Alfred Mahr, Luc Mouthon, Philippe Le Toumelin
I whakaputaina 2010Artigo -
16
-
17
Hepatitis B Virus-Associated Polyarteritis Nodosa mā Loı̈c Guillevin, Alfred Mahr, P Callard, Pascal Godmer, Christian Pagnoux, Emmanuelle Leray, Pascal Cohen
I whakaputaina 2005Artigo -
18
-
19
-
20
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Disease
Vasculitis
Gastroenterology
Immunology
Pathology
Surgery
Microscopic polyangiitis
Granulomatosis with polyangiitis
Chemotherapy
Biology
Antibody
Anti-neutrophil cytoplasmic antibody
Dermatology
Cyclophosphamide
Systemic vasculitis
Polyarteritis nodosa
Intensive care medicine
Lymphoma
Environmental health
Physics
Population
Confidence interval
Adverse effect
Biochemistry
Kidney
Maintenance therapy
Retrospective cohort study
Rheumatology